LifeStance Health ROE 2020-2026 | LFST
Current and historical return on equity (ROE) values for LifeStance Health (LFST) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| LifeStance Health ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2026-03-31 | $0.02B | $1.49B | 1.54% |
| 2025-12-31 | $0.01B | $1.49B | 0.67% |
| 2025-09-30 | $-0.01B | $1.47B | -0.61% |
| 2025-06-30 | $-0.02B | $1.45B | -1.10% |
| 2025-03-31 | $-0.04B | $1.44B | -2.43% |
| 2024-12-31 | $-0.06B | $1.44B | -3.97% |
| 2024-09-30 | $-0.10B | $1.43B | -6.64% |
| 2024-06-30 | $-0.15B | $1.44B | -10.52% |
| 2024-03-31 | $-0.17B | $1.45B | -11.91% |
| 2023-12-31 | $-0.19B | $1.47B | -12.64% |
| 2023-09-30 | $-0.19B | $1.49B | -12.59% |
| 2023-06-30 | $-0.16B | $1.51B | -10.84% |
| 2023-03-31 | $-0.19B | $1.52B | -12.35% |
| 2022-12-31 | $-0.22B | $1.53B | -14.11% |
| 2022-09-30 | $-0.28B | $1.54B | -18.01% |
| 2022-06-30 | $-0.36B | $1.54B | -23.30% |
| 2022-03-31 | $-0.36B | $1.55B | -23.31% |
| 2021-12-31 | $-0.34B | $1.40B | -24.55% |
| 2021-09-30 | $-0.24B | $1.26B | -19.04% |
| 2021-06-30 | $-0.12B | $0.87B | -14.07% |
| 2021-03-31 | $-0.09B | $0.49B | -17.42% |
| 2020-12-31 | $-0.04B | $0.25B | -15.23% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $2.495B | $1.424B |
| LifeStance Health Group Inc. is provider of virtual and in-person outpatient mental health care for children, adolescents and adults of mental health conditions. LifeStance Health Group Inc. is based in SCOTTSDALE, Ariz. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |